Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression

RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technolog...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 144; no. 50; pp. 23061 - 23072
Main Authors Fang, Jing, Feng, Yali, Zhang, Yuqi, Wang, Anna, Li, Jiachen, Cui, Chaoxiang, Guo, Yirui, Zhu, Jinfeng, Lv, Zhengzhong, Zhao, Zhongsheng, Xu, Chenjie, Shi, Haibin
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 21.12.2022
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.
AbstractList RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALPresponsive NIR fluorogenic probe f-RCP consisting of a tumortargeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.
RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.
RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe -RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an O -susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that -RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of -RCP producing singlet oxygen ( O ) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.
RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.
Author Fang, Jing
Lv, Zhengzhong
Zhu, Jinfeng
Shi, Haibin
Li, Jiachen
Zhang, Yuqi
Xu, Chenjie
Zhao, Zhongsheng
Cui, Chaoxiang
Feng, Yali
Wang, Anna
Guo, Yirui
AuthorAffiliation The Second Affiliated Hospital of Soochow University
State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
City University of Hong Kong
Department of Biomedical Engineering
Department of Radiology
AuthorAffiliation_xml – name: Department of Radiology
– name: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– name: Department of Biomedical Engineering
– name: The Second Affiliated Hospital of Soochow University
– name: City University of Hong Kong
Author_xml – sequence: 1
  givenname: Jing
  surname: Fang
  fullname: Fang, Jing
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 2
  givenname: Yali
  surname: Feng
  fullname: Feng, Yali
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 3
  givenname: Yuqi
  surname: Zhang
  fullname: Zhang, Yuqi
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 4
  givenname: Anna
  surname: Wang
  fullname: Wang, Anna
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 5
  givenname: Jiachen
  surname: Li
  fullname: Li, Jiachen
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 6
  givenname: Chaoxiang
  surname: Cui
  fullname: Cui, Chaoxiang
  organization: The Second Affiliated Hospital of Soochow University
– sequence: 7
  givenname: Yirui
  surname: Guo
  fullname: Guo, Yirui
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 8
  givenname: Jinfeng
  surname: Zhu
  fullname: Zhu, Jinfeng
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 9
  givenname: Zhengzhong
  surname: Lv
  fullname: Lv, Zhengzhong
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 10
  givenname: Zhongsheng
  surname: Zhao
  fullname: Zhao, Zhongsheng
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
– sequence: 11
  givenname: Chenjie
  orcidid: 0000-0002-8278-3912
  surname: Xu
  fullname: Xu, Chenjie
  organization: City University of Hong Kong
– sequence: 12
  givenname: Haibin
  orcidid: 0000-0003-2234-9126
  surname: Shi
  fullname: Shi, Haibin
  email: hbshi@suda.edu.cn
  organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36503221$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1v1DAQxS1URLeFG2eUIxKk-CNO4mMUFYq0QFXKOXLsMesla29tB8R_j7ebckAgcbLH83tj-70zdOK8A4SeE3xBMCVvtlLFC6oIrrB4hFaEU1xyQusTtMIY07Jpa3aKzmLc5rKiLXmCTlnNMaOUrNBdN32Tk3VQXG983G9kkhHK3rsU_DTJcYJCOl3cgC7W9usmlZ1K9rtMub752BUfvLbGKpmsd0W33wcv1aYwPhTXAZSNUNzOu1x9nnMPYszYU_TYyCnCs2U9R1_eXt72V-X607v3fbcuJaNVKkdDBWmF1sxowznjmgvScMF0w2QFWKuRUypM3TaVHhtudGsabLgiDaFACTtHL49z86PuZohp2NmoIH_KgZ_jQBvO6rqpBMvoiwWdxx3oYR_sToafw4NNGXh1BH7A6E1UFpyC31j2tRW1wETkHT7Q7f_TvU337vV-dilL6VGqgo8xgBnU0k9B2mkgeDiEPhxCH5bQs-j1H6KHu_6BL8YcDrd-Di7H8Hf0F3wRuWI
CitedBy_id crossref_primary_10_1039_D3AN01761C
crossref_primary_10_1002_anie_202411598
crossref_primary_10_1021_cbmi_3c00030
crossref_primary_10_1038_s41467_025_56691_3
crossref_primary_10_1002_ange_202317773
crossref_primary_10_1021_cbmi_3c00078
crossref_primary_10_1039_D2CS00999D
crossref_primary_10_1002_anie_202410649
crossref_primary_10_1039_D3CC01778H
crossref_primary_10_1021_jacs_4c17092
crossref_primary_10_1002_anie_202317773
crossref_primary_10_1021_acsmaterialslett_3c00790
crossref_primary_10_1002_adhm_202304108
crossref_primary_10_1002_anie_202218969
crossref_primary_10_1002_ange_202410649
crossref_primary_10_1021_acsami_4c11112
crossref_primary_10_1007_s11426_023_1606_8
crossref_primary_10_1021_acs_biomac_3c01413
crossref_primary_10_1021_acs_jmedchem_4c00355
crossref_primary_10_1016_j_talanta_2024_126477
crossref_primary_10_1016_j_nantod_2023_102111
crossref_primary_10_1002_ange_202411598
crossref_primary_10_1039_D2SC06413H
crossref_primary_10_1039_D3CB00073G
crossref_primary_10_1016_j_snb_2024_136178
crossref_primary_10_1002_cbic_202400516
crossref_primary_10_1016_j_cclet_2025_111061
crossref_primary_10_1016_j_nantod_2024_102478
crossref_primary_10_1002_asia_202400189
crossref_primary_10_1021_acs_analchem_3c04033
crossref_primary_10_1039_D3MD00565H
crossref_primary_10_1002_asia_202300756
crossref_primary_10_1021_acs_analchem_3c04845
crossref_primary_10_1002_cbic_202300633
crossref_primary_10_1080_21691401_2024_2368033
crossref_primary_10_1002_smo_20240031
crossref_primary_10_1021_acsnano_5c00268
crossref_primary_10_1002_adhm_202403243
crossref_primary_10_1002_ange_202218969
Cites_doi 10.1038/s41467-022-29284-7
10.1021/acsnano.6b07600
10.1021/acsami.1c02122
10.1021/jacs.5b01435
10.1038/s41467-022-29790-8
10.1039/c5cc09248e
10.1038/s41557-020-0514-4
10.1038/s41565-021-00898-0
10.1021/acs.analchem.2c00098
10.1039/c9sc03355f
10.1021/jacs.0c10755
10.1038/nature.2016.20535
10.1021/jacs.8b13628
10.1021/jacs.8b10558
10.1186/s12943-022-01508-w
10.1038/s41563-019-0378-4
10.1021/acs.chemrev.1c00244
10.1021/ja512293f
10.1038/nature13187
10.1039/c7cs00479f
10.1002/adma.202003523
10.1039/d0cs00560f
10.1021/jacs.7b07582
10.1002/adma.201902575
10.1021/jacs.8b05341
10.1021/nn102055s
10.1056/nejmoa2022483
10.1002/anie.202011174
10.1038/s41573-020-0090-8
10.1002/adma.201801570
10.1016/j.cell.2009.02.007
10.1038/s41586-019-1711-4
10.1021/ja500962u
10.1021/acsami.1c21062
10.1021/cr5006793
10.1039/d0cs01261k
10.1021/jacs.0c08996
10.1002/adma.202110618
10.1002/anie.201300754
10.1021/jacs.1c08898
10.1152/ajplung.1999.277.3.l573
10.1038/s41594-019-0200-7
10.1038/s41467-018-04048-4
10.1021/jacs.0c12044
10.1002/anie.202109863
10.1021/ja301901p
10.1021/jacs.1c00570
10.1021/jacs.0c12043
10.1021/jacs.1c08860
10.1021/acs.bioconjchem.8b00749
10.1021/cr500542t
10.1021/acs.jmedchem.9b01927
10.1021/ja800086u
10.1007/s12274-021-3616-4
10.1038/nrd.2018.93
10.1021/acs.jmedchem.0c00840
10.1126/science.aam8526
10.1126/science.1233158
10.1021/acs.bioconjchem.8b00688
10.1021/ja300174v
10.1016/j.chempr.2018.08.003
10.1056/NEJMoa2022483
ContentType Journal Article
Copyright 2022 American Chemical Society
Copyright_xml – notice: 2022 American Chemical Society
DBID AAYXX
CITATION
17B
1KM
AHQBO
BLEPL
DTL
EGQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/jacs.2c10409
DatabaseName CrossRef
Web of Knowledge
Index Chemicus
Web of Science - Science Citation Index Expanded - 2022
Web of Science Core Collection
Science Citation Index Expanded
Web of Science Primary (SCIE, SSCI & AHCI)
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList Web of Science

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1520-5126
EndPage 23072
ExternalDocumentID 36503221
000896901900001
10_1021_jacs_2c10409
a364479660
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Training Program of the Major Research Plan of the National Natural Science Foundation of China; National Natural Science Foundation of China (NSFC)
  grantid: 91959123
– fundername: National Science Foundation of China; National Natural Science Foundation of China (NSFC)
  grantid: 22077092
– fundername: Open Project Program of the State Key Laboratory of Radiation Medicine and Protection
  grantid: GZK1202132; GZK1202140; GZK1202017
– fundername: Priority Academic Program Development of Jiangsu Higher Education Institutions
GroupedDBID ---
-DZ
-ET
-~X
.DC
.K2
4.4
55A
5GY
5RE
5VS
7~N
85S
8W4
AABXI
ABFLS
ABFRP
ABMVS
ABPPZ
ABPTK
ABQRX
ABUCX
ACGFO
ACGFS
ACJ
ACNCT
ACS
ADHLV
AEESW
AENEX
AFEFF
AGXLV
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
BKOMP
CS3
DU5
EBS
ED~
F5P
GGK
GNL
IH2
IH9
JG~
LG6
P2P
ROL
RXW
TAE
TAF
TN5
UHB
UI2
UKR
UPT
VF5
VG9
VQA
W1F
WH7
XSW
YQT
YZZ
ZCA
~02
53G
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ACBEA
AHGAQ
CITATION
CUPRZ
17B
1KM
AAYWT
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
GROUPED_WOS_WEB_OF_SCIENCE
CGR
CUY
CVF
ECM
EIF
NPM
YIN
7X8
ID FETCH-LOGICAL-a324t-bf29189dd3fdf5535d5917593d73a4e0dcb5229f6874db75fd8f70f5c1712e213
IEDL.DBID ACS
ISICitedReferencesCount 37
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000896901900001
ISSN 0002-7863
1520-5126
IngestDate Fri Jul 11 07:26:53 EDT 2025
Wed Feb 19 02:25:37 EST 2025
Fri Aug 29 16:19:23 EDT 2025
Tue Jul 22 03:02:15 EDT 2025
Tue Jul 01 03:54:22 EDT 2025
Thu Apr 24 23:05:49 EDT 2025
Fri Dec 23 04:37:03 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 50
Keywords STRATEGY
MITOCHONDRIA
CROSS-LINKING
RECEPTOR
SELECTIVE DETECTION
DELIVERY
PROBES
Language English
License https://doi.org/10.15223/policy-029
https://doi.org/10.15223/policy-037
https://doi.org/10.15223/policy-045
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-a324t-bf29189dd3fdf5535d5917593d73a4e0dcb5229f6874db75fd8f70f5c1712e213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8278-3912
0000-0003-2234-9126
PMID 36503221
PQID 2753667493
PQPubID 23479
PageCount 12
ParticipantIDs webofscience_primary_000896901900001
proquest_miscellaneous_2753667493
pubmed_primary_36503221
crossref_citationtrail_10_1021_jacs_2c10409
crossref_primary_10_1021_jacs_2c10409
webofscience_primary_000896901900001CitationCount
acs_journals_10_1021_jacs_2c10409
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20221221
2022-12-21
PublicationDateYYYYMMDD 2022-12-21
PublicationDate_xml – month: 12
  year: 2022
  text: 20221221
  day: 21
PublicationDecade 2020
PublicationPlace WASHINGTON
PublicationPlace_xml – name: WASHINGTON
– name: United States
PublicationTitle Journal of the American Chemical Society
PublicationTitleAbbrev J AM CHEM SOC
PublicationTitleAlternate J. Am. Chem. Soc
PublicationYear 2022
Publisher American Chemical Society
Amer Chemical Soc
Publisher_xml – name: American Chemical Society
– name: Amer Chemical Soc
References ref9/cit9
ref45/cit45
ref3/cit3
ref27/cit27
ref56/cit56
ref16/cit16
ref52/cit52
ref23/cit23
ref8/cit8
ref31/cit31
ref59/cit59
ref2/cit2
ref34/cit34
ref37/cit37
ref20/cit20
ref48/cit48
ref60/cit60
ref17/cit17
ref10/cit10
ref35/cit35
ref53/cit53
ref19/cit19
ref21/cit21
ref42/cit42
ref46/cit46
ref49/cit49
ref13/cit13
ref61/cit61
ref24/cit24
ref38/cit38
ref50/cit50
ref54/cit54
ref6/cit6
ref36/cit36
ref18/cit18
ref11/cit11
ref25/cit25
ref29/cit29
ref32/cit32
ref39/cit39
ref14/cit14
ref57/cit57
ref5/cit5
ref51/cit51
ref43/cit43
ref28/cit28
ref40/cit40
ref26/cit26
ref55/cit55
ref12/cit12
ref15/cit15
ref41/cit41
ref58/cit58
ref22/cit22
ref33/cit33
ref4/cit4
ref30/cit30
ref47/cit47
ref1/cit1
ref44/cit44
ref7/cit7
Sun, L (WOS:000463168900014) 2019; 26
Su, ZL (WOS:000784989100008) 2022; 13
Li, J (WOS:000349138600008) 2015; 137
Schmidt, MJ (WOS:000318043600036) 2013; 52
Warner, KD (WOS:000440162900013) 2018; 17
Xie, RS (WOS:000788376600001) 2022; 34
Liu, J (WOS:000481909600027) 2019; 31
Knutson, SD (WOS:000579400400064) 2020; 142
Wang, YY (WOS:000459642100007) 2019; 30
Biffi, A (WOS:000323370600034) 2013; 341
Dunn, SS (WOS:000303362900048) 2012; 134
Childs-Disney, JL (WOS:000447051500020) 2018; 4
Chen, XC (WOS:000750799000016) 2021; 143
Weng, JH (WOS:000715845900048) 2021; 143
Zhang, YB (WOS:000713054600004) 2021; 121
Xu, Z (WOS:000368353600002) 2016; 52
Mitchell, MJ (WOS:000598984300001) 2021; 20
Jackson, LA (WOS:000588782400009) 2020; 383
Thakore, PI (WOS:000430922900004) 2018; 9
Ye, L (WOS:000678460700003) 2022; 15
Yezhelyev, MV (WOS:000257507400030) 2008; 130
Lim, SY (WOS:000336078400046) 2014; 136
Op de Beeck, M (WOS:000305863900006) 2012; 134
Fang, HP (WOS:000446142500019) 2018; 140
Haniff, HS (WOS:000562733000001) 2020; 12
Huang, JG (WOS:000486618800024) 2019; 18
Lächelt, U (WOS:000363002300014) 2015; 115
Wang, Q (WOS:000651748000020) 2021; 143
Liu, HM (WOS:000600926000001) 2021; 33
Yang, JP (WOS:000356316300015) 2015; 115
Chen, J (WOS:000459642100008) 2019; 30
Nie, JJ (WOS:000443807400018) 2018; 30
Ledford, H (WOS:000383098000015) 2016; 537
Kulkarni, JA (WOS:000656429700001) 2021; 16
Liu, JB (WOS:000591755900001) 2021; 60
Cleary, AS (WOS:000333609900053) 2014; 508
Fang, J (WOS:000779305600034) 2022; 94
Knerr, L (WOS:000629075900019) 2021; 143
Ye, SY (WOS:000603395100031) 2020; 142
Zhang, YQ (WOS:000776282500026) 2022; 13
Sharp, PA (WOS:000263688200007) 2009; 136
Yin, L (WOS:000459642000061) 2019; 141
Anzalone, AV (WOS:000501599200056) 2019; 576
Shen, JL (WOS:000429201500004) 2018; 47
Meyer, SM (WOS:000575023000010) 2020; 49
Mao, QL (WOS:000702320500001) 2021; 60
Costales, MG (WOS:000571493400002) 2020; 63
Tang, WT (WOS:000651750000005) 2021; 13
Malek-Adarnian, E (WOS:000413503300034) 2017; 139
Falese, JP (WOS:000624298500001) 2021; 50
Mout, R (WOS:000398014900012) 2017; 11
Piwecka, M (WOS:000411337700036) 2017; 357
Huang, XH (WOS:000283453700055) 2010; 4
Nikan, M (WOS:000562941200036) 2020; 63
Hattori, N (WOS:000082425100017) 1999; 277
Fang, Y (WOS:000614064400007) 2021; 143
Xu, F (WOS:000498611100014) 2019; 10
Wang, AN (WOS:000731610800001) 2021; 13
Costales, MG (WOS:000459642000029) 2019; 141
Liu, L (WOS:000749200200002) 2022; 21
Sun, Q (WOS:000354910500026) 2015; 137
References_xml – ident: ref14/cit14
  doi: 10.1038/s41467-022-29284-7
– ident: ref20/cit20
  doi: 10.1021/acsnano.6b07600
– ident: ref21/cit21
  doi: 10.1021/acsami.1c02122
– ident: ref44/cit44
  doi: 10.1021/jacs.5b01435
– ident: ref49/cit49
  doi: 10.1038/s41467-022-29790-8
– ident: ref61/cit61
  doi: 10.1039/c5cc09248e
– ident: ref37/cit37
  doi: 10.1038/s41557-020-0514-4
– ident: ref6/cit6
  doi: 10.1038/s41565-021-00898-0
– ident: ref57/cit57
  doi: 10.1021/acs.analchem.2c00098
– ident: ref59/cit59
  doi: 10.1039/c9sc03355f
– ident: ref52/cit52
  doi: 10.1021/jacs.0c10755
– ident: ref1/cit1
  doi: 10.1038/nature.2016.20535
– ident: ref58/cit58
  doi: 10.1021/jacs.8b13628
– ident: ref36/cit36
  doi: 10.1021/jacs.8b10558
– ident: ref46/cit46
  doi: 10.1186/s12943-022-01508-w
– ident: ref55/cit55
  doi: 10.1038/s41563-019-0378-4
– ident: ref28/cit28
  doi: 10.1021/acs.chemrev.1c00244
– ident: ref25/cit25
  doi: 10.1021/ja512293f
– ident: ref2/cit2
  doi: 10.1038/nature13187
– ident: ref18/cit18
  doi: 10.1039/c7cs00479f
– ident: ref17/cit17
  doi: 10.1002/adma.202003523
– ident: ref30/cit30
  doi: 10.1039/d0cs00560f
– ident: ref34/cit34
  doi: 10.1021/jacs.7b07582
– ident: ref26/cit26
  doi: 10.1002/adma.201902575
– ident: ref22/cit22
  doi: 10.1021/jacs.8b05341
– ident: ref54/cit54
  doi: 10.1021/nn102055s
– ident: ref11/cit11
  doi: 10.1056/nejmoa2022483
– ident: ref24/cit24
  doi: 10.1002/anie.202011174
– ident: ref3/cit3
  doi: 10.1038/s41573-020-0090-8
– ident: ref12/cit12
  doi: 10.1002/adma.201801570
– ident: ref27/cit27
  doi: 10.1016/j.cell.2009.02.007
– ident: ref19/cit19
  doi: 10.1038/s41586-019-1711-4
– ident: ref60/cit60
  doi: 10.1021/ja500962u
– ident: ref5/cit5
  doi: 10.1021/acsami.1c21062
– ident: ref9/cit9
  doi: 10.1021/cr5006793
– ident: ref41/cit41
  doi: 10.1039/d0cs01261k
– ident: ref47/cit47
  doi: 10.1021/jacs.0c08996
– ident: ref13/cit13
  doi: 10.1002/adma.202110618
– ident: ref51/cit51
  doi: 10.1002/anie.201300754
– ident: ref56/cit56
  doi: 10.1021/jacs.1c08898
– ident: ref53/cit53
  doi: 10.1152/ajplung.1999.277.3.l573
– ident: ref45/cit45
  doi: 10.1038/s41594-019-0200-7
– ident: ref15/cit15
  doi: 10.1038/s41467-018-04048-4
– ident: ref33/cit33
  doi: 10.1021/jacs.0c12044
– ident: ref4/cit4
  doi: 10.1002/anie.202109863
– ident: ref50/cit50
  doi: 10.1021/ja301901p
– ident: ref48/cit48
  doi: 10.1021/jacs.1c00570
– ident: ref32/cit32
  doi: 10.1021/jacs.0c12043
– ident: ref38/cit38
  doi: 10.1021/jacs.1c08860
– ident: ref10/cit10
  doi: 10.1021/acs.bioconjchem.8b00749
– ident: ref7/cit7
  doi: 10.1021/cr500542t
– ident: ref39/cit39
  doi: 10.1021/acs.jmedchem.9b01927
– ident: ref43/cit43
  doi: 10.1021/ja800086u
– ident: ref42/cit42
  doi: 10.1007/s12274-021-3616-4
– ident: ref35/cit35
  doi: 10.1038/nrd.2018.93
– ident: ref31/cit31
  doi: 10.1021/acs.jmedchem.0c00840
– ident: ref29/cit29
  doi: 10.1126/science.aam8526
– ident: ref8/cit8
  doi: 10.1126/science.1233158
– ident: ref23/cit23
  doi: 10.1021/acs.bioconjchem.8b00688
– ident: ref16/cit16
  doi: 10.1021/ja300174v
– ident: ref40/cit40
  doi: 10.1016/j.chempr.2018.08.003
– volume: 49
  start-page: 7167
  year: 2020
  ident: WOS:000575023000010
  article-title: Small molecule recognition of disease-relevant RNA structures
  publication-title: CHEMICAL SOCIETY REVIEWS
  doi: 10.1039/d0cs00560f
– volume: 30
  start-page: ARTN 1801570
  year: 2018
  ident: WOS:000443807400018
  article-title: Unlockable Nanocomplexes with Self-Accelerating Nucleic Acid Release for Effective Staged Gene Therapy of Cardiovascular Diseases
  publication-title: ADVANCED MATERIALS
  doi: 10.1002/adma.201801570
– volume: 50
  start-page: 2224
  year: 2021
  ident: WOS:000624298500001
  article-title: Targeting RNA with small molecules: from fundamental principles towards the clinic
  publication-title: CHEMICAL SOCIETY REVIEWS
  doi: 10.1039/d0cs01261k
– volume: 9
  start-page: ARTN 1674
  year: 2018
  ident: WOS:000430922900004
  article-title: RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
  publication-title: NATURE COMMUNICATIONS
  doi: 10.1038/s41467-018-04048-4
– volume: 139
  start-page: 14542
  year: 2017
  ident: WOS:000413503300034
  article-title: 4′-C-Methoxy-2′-deoxy-2′-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene Silencing
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.7b07582
– volume: 141
  start-page: 3265
  year: 2019
  ident: WOS:000459642000061
  article-title: Quantitatively Visualizing Tumor-Related Protease Activity in Vivo Using a Ratiometric Photoacoustic Probe
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.8b13628
– volume: 13
  start-page: ARTN 1685
  year: 2022
  ident: WOS:000776282500026
  article-title: A hydrogen sulphide-responsive and depleting nanoplatform for cancer photodynamic therapy
  publication-title: NATURE COMMUNICATIONS
  doi: 10.1038/s41467-022-29284-7
– volume: 18
  start-page: 1133
  year: 2019
  ident: WOS:000486618800024
  article-title: Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury
  publication-title: NATURE MATERIALS
  doi: 10.1038/s41563-019-0378-4
– volume: 52
  start-page: 1094
  year: 2016
  ident: WOS:000368353600002
  article-title: Fluorescent probes for the selective detection of chemical species inside mitochondria
  publication-title: CHEMICAL COMMUNICATIONS
  doi: 10.1039/c5cc09248e
– volume: 16
  start-page: 630
  year: 2021
  ident: WOS:000656429700001
  article-title: The current landscape of nucleic acid therapeutics
  publication-title: NATURE NANOTECHNOLOGY
  doi: 10.1038/s41565-021-00898-0
– volume: 143
  start-page: 1296
  year: 2021
  ident: WOS:000614064400007
  article-title: Spherical Nucleic Acids for Topical Treatment of Hyperpigmentation
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.0c12044
– volume: 121
  start-page: 12181
  year: 2021
  ident: WOS:000713054600004
  article-title: Lipids and Lipid Derivatives for RNA Delivery
  publication-title: CHEMICAL REVIEWS
  doi: 10.1021/acs.chemrev.1c00244
– volume: 60
  start-page: 23805
  year: 2021
  ident: WOS:000702320500001
  article-title: Aggregation of Gold Nanoparticles Triggered by Hydrogen Peroxide-Initiated Chemiluminescence for Activated Tumor Theranostics
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.202109863
– volume: 21
  start-page: ARTN 32
  year: 2022
  ident: WOS:000749200200002
  article-title: Insights into N6-methyladenosine and programmed cell death in cancer
  publication-title: MOLECULAR CANCER
  doi: 10.1186/s12943-022-01508-w
– volume: 11
  start-page: 2452
  year: 2017
  ident: WOS:000398014900012
  article-title: Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing
  publication-title: ACS NANO
  doi: 10.1021/acsnano.6b07600
– volume: 30
  start-page: 338
  year: 2019
  ident: WOS:000459642100008
  article-title: Polycations for Gene Delivery: Dilemmas and Solutions
  publication-title: BIOCONJUGATE CHEMISTRY
  doi: 10.1021/acs.bioconjchem.8b00688
– volume: 13
  start-page: ARTN 2165
  year: 2022
  ident: WOS:000784989100008
  article-title: TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer
  publication-title: NATURE COMMUNICATIONS
  doi: 10.1038/s41467-022-29790-8
– volume: 31
  start-page: ARTN 1902575
  year: 2019
  ident: WOS:000481909600027
  article-title: Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
  publication-title: ADVANCED MATERIALS
  doi: 10.1002/adma.201902575
– volume: 130
  start-page: 9006
  year: 2008
  ident: WOS:000257507400030
  article-title: Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja800086u
– volume: 143
  start-page: 18294
  year: 2021
  ident: WOS:000715845900048
  article-title: An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.1c08898
– volume: 143
  start-page: 6895
  year: 2021
  ident: WOS:000651748000020
  article-title: Orthogonal Demethylase-Activated Deoxyribozyme for Intracellular Imaging and Gene Regulation
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.1c00570
– volume: 137
  start-page: 1412
  year: 2015
  ident: WOS:000349138600008
  article-title: Self-assembly of DNA Nanohydrogels with Controllable Size and Stimuli-Responsive Property for Targeted Gene Regulation Therapy
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja512293f
– volume: 34
  start-page: ARTN 2110618
  year: 2022
  ident: WOS:000788376600001
  article-title: pH-Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA
  publication-title: ADVANCED MATERIALS
  doi: 10.1002/adma.202110618
– volume: 15
  start-page: 1135
  year: 2022
  ident: WOS:000678460700003
  article-title: Enhanced endosomal escape of dendrigraft poly-L-lysine polymers for the efficient gene therapy of breast cancer
  publication-title: NANO RESEARCH
  doi: 10.1007/s12274-021-3616-4
– volume: 63
  start-page: 8471
  year: 2020
  ident: WOS:000562941200036
  article-title: Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/acs.jmedchem.0c00840
– volume: 10
  start-page: 10586
  year: 2019
  ident: WOS:000498611100014
  article-title: Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy
  publication-title: CHEMICAL SCIENCE
  doi: 10.1039/c9sc03355f
– volume: 20
  start-page: 101
  year: 2021
  ident: WOS:000598984300001
  article-title: Engineering precision nanoparticles for drug delivery
  publication-title: NATURE REVIEWS DRUG DISCOVERY
  doi: 10.1038/s41573-020-0090-8
– volume: 115
  start-page: 11043
  year: 2015
  ident: WOS:000363002300014
  article-title: Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
  publication-title: CHEMICAL REVIEWS
  doi: 10.1021/cr5006793
– volume: 60
  start-page: 1853
  year: 2021
  ident: WOS:000591755900001
  article-title: Branched Antisense and siRNA Co-Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.202011174
– volume: 33
  start-page: ARTN 2003523
  year: 2021
  ident: WOS:000600926000001
  article-title: Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy
  publication-title: ADVANCED MATERIALS
  doi: 10.1002/adma.202003523
– volume: 30
  start-page: 325
  year: 2019
  ident: WOS:000459642100007
  article-title: Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems
  publication-title: BIOCONJUGATE CHEMISTRY
  doi: 10.1021/acs.bioconjchem.8b00749
– volume: 141
  start-page: 2960
  year: 2019
  ident: WOS:000459642000029
  article-title: A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.8b10558
– volume: 26
  start-page: 322
  year: 2019
  ident: WOS:000463168900014
  article-title: RNA structure maps across mammalian cellular compartments
  publication-title: NATURE STRUCTURAL & MOLECULAR BIOLOGY
  doi: 10.1038/s41594-019-0200-7
– volume: 341
  start-page: 864
  year: 2013
  ident: WOS:000323370600034
  article-title: Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
  publication-title: SCIENCE
  doi: 10.1126/science.1233158
– volume: 13
  start-page: 59787
  year: 2021
  ident: WOS:000731610800001
  article-title: Assembly Transformation Jointly Driven by the LAP Enzyme and GSH Boosting Theranostic Capability for Effective Tumor Therapy
  publication-title: ACS APPLIED MATERIALS & INTERFACES
  doi: 10.1021/acsami.1c21062
– volume: 142
  start-page: 17766
  year: 2020
  ident: WOS:000579400400064
  article-title: Thermoreversible Control of Nucleic Acid Structure and Function with Glyoxal Caging
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.0c08996
– volume: 508
  start-page: 113
  year: 2014
  ident: WOS:000333609900053
  article-title: Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
  publication-title: NATURE
  doi: 10.1038/nature13187
– volume: 140
  start-page: 11992
  year: 2018
  ident: WOS:000446142500019
  article-title: Molecular Strings Significantly Improved the Gene Transfection Efficiency of Polycations
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.8b05341
– volume: 143
  start-page: 3416
  year: 2021
  ident: WOS:000629075900019
  article-title: Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.0c12043
– volume: 17
  start-page: 547
  year: 2018
  ident: WOS:000440162900013
  article-title: Principles for targeting RNA with drug-like small molecules
  publication-title: NATURE REVIEWS DRUG DISCOVERY
  doi: 10.1038/nrd.2018.93
– volume: 47
  start-page: 1969
  year: 2018
  ident: WOS:000429201500004
  article-title: Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics
  publication-title: CHEMICAL SOCIETY REVIEWS
  doi: 10.1039/c7cs00479f
– volume: 383
  start-page: 1920
  year: 2020
  ident: WOS:000588782400009
  article-title: An mRNA Vaccine against SARS-CoV-2-Preliminary Report
  publication-title: NEW ENGLAND JOURNAL OF MEDICINE
  doi: 10.1056/NEJMoa2022483
– volume: 12
  start-page: 952
  year: 2020
  ident: WOS:000562733000001
  article-title: Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions
  publication-title: NATURE CHEMISTRY
  doi: 10.1038/s41557-020-0514-4
– volume: 576
  start-page: 149
  year: 2019
  ident: WOS:000501599200056
  article-title: Search-and-replace genome editing without double-strand breaks or donor DNA
  publication-title: NATURE
  doi: 10.1038/s41586-019-1711-4
– volume: 115
  start-page: 5274
  year: 2015
  ident: WOS:000356316300015
  article-title: Surface-Engineered Dendrimers in Gene Delivery
  publication-title: CHEMICAL REVIEWS
  doi: 10.1021/cr500542t
– volume: 52
  start-page: 4690
  year: 2013
  ident: WOS:000318043600036
  article-title: Red-Light-Controlled ProteinRNA Crosslinking with a Genetically Encoded Furan
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.201300754
– volume: 537
  start-page: 288
  year: 2016
  ident: WOS:000383098000015
  article-title: Wishlist set for cancer 'moonshot'
  publication-title: NATURE
– volume: 357
  start-page: ARTN eaam8526
  year: 2017
  ident: WOS:000411337700036
  article-title: Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function
  publication-title: SCIENCE
  doi: 10.1126/science.aam8526
– volume: 134
  start-page: 7423
  year: 2012
  ident: WOS:000303362900048
  article-title: Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja300174v
– volume: 136
  start-page: 577
  year: 2009
  ident: WOS:000263688200007
  article-title: The Centrality of RNA
  publication-title: CELL
  doi: 10.1016/j.cell.2009.02.007
– volume: 277
  start-page: L573
  year: 1999
  ident: WOS:000082425100017
  article-title: Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung
  publication-title: AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
– volume: 136
  start-page: 7018
  year: 2014
  ident: WOS:000336078400046
  article-title: Tunable Heptamethine-Azo Dye Conjugate as an NIR Fluorescent Probe for the Selective Detection of Mitochondria! Glutathione over Cysteine and Homocysteine
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja500962u
– volume: 4
  start-page: 5887
  year: 2010
  ident: WOS:000283453700055
  article-title: A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands
  publication-title: ACS NANO
  doi: 10.1021/nn102055s
– volume: 13
  start-page: 20974
  year: 2021
  ident: WOS:000651750000005
  article-title: A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy
  publication-title: ACS APPLIED MATERIALS & INTERFACES
  doi: 10.1021/acsami.1c02122
– volume: 142
  start-page: 21502
  year: 2020
  ident: WOS:000603395100031
  article-title: Red Light-Initiated Cross-Linking of NIR Probes to Cytoplasmic RNA: An Innovative Strategy for Prolonged Imaging and Unexpected Tumor Suppression
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.0c10755
– volume: 143
  start-page: 20779
  year: 2021
  ident: WOS:000750799000016
  article-title: Monitoring and Modulating mtDNA G-Quadruplex Dynamics Reveal Its Close Relationship to Cell Glycolysis
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.1c08860
– volume: 137
  start-page: 6000
  year: 2015
  ident: WOS:000354910500026
  article-title: A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.5b01435
– volume: 63
  start-page: 8880
  year: 2020
  ident: WOS:000571493400002
  article-title: How We Think about Targeting RNA with Small Molecules
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/acs.jmedchem.9b01927
– volume: 134
  start-page: 10737
  year: 2012
  ident: WOS:000305863900006
  article-title: Sequence Specific DNA Cross-Linking Triggered by Visible Light
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja301901p
– volume: 4
  start-page: 2384
  year: 2018
  ident: WOS:000447051500020
  article-title: A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence
  publication-title: CHEM
  doi: 10.1016/j.chempr.2018.08.003
– volume: 94
  start-page: 5149
  year: 2022
  ident: WOS:000779305600034
  article-title: In Vivo Quantitative Assessment of a Radiation Dose Based on Ratiometric Photoacoustic Imaging of Tumor Apoptosis
  publication-title: ANALYTICAL CHEMISTRY
  doi: 10.1021/acs.analchem.2c00098
SSID ssj0004281
Score 2.5531003
Snippet RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical...
Source Web of Science
SourceID proquest
pubmed
webofscience
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 23061
SubjectTerms Alkaline Phosphatase
Chemistry
Chemistry, Multidisciplinary
Fluorescent Dyes - chemistry
Humans
Light
Neoplasms
Physical Sciences
RNA
Science & Technology
Title Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression
URI http://dx.doi.org/10.1021/jacs.2c10409
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000896901900001
https://www.ncbi.nlm.nih.gov/pubmed/36503221
https://www.proquest.com/docview/2753667493
Volume 144
WOS 000896901900001
WOSCitedRecordID wos000896901900001
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELYqemgvfUFL-pKR6Al5tbbjJD5GUSlCBSEeEreVn0JiyUKTvfTXdyaPhUJROTqZRIpnnPlGM_MNIduFDanOomM6RMFS6w0zwURWCOmUsXFqDDYKHxxme2fp_rk6vy2QvZ_BF8gP5JqJcBA2YJ_ec5HB-UUIVJ3c9j-Kgo8wNy8yORS4338aHZBr_nZAD1DlPx1Q52x2X5MfY8tOX2NyOVm2duJ-P2Rw_M93vCGvBrxJy95A3pJnoX5HXlTjmLd1clPOLw1iTXp0sWiuL0wLfo1VfQX7HBurqKk9PQ6e_uxIR0rXTUSD9fFhSQ8WHouNOv3SciAop4CE6RHyZjSBni6vYIXTQ_uS23qDnO1-P6322DCHgRmAWy2zUWheaO9l9FEpqbyCIE9p6XNp0jD1zgKK0xE0k3qbq-iLmE-jcjznIggu35O1elGHTUINAq6Q6ymgxjRzED9JZz2eVPClStqEbME2zYZz1My6FLmAEAWvDpuXkJ1RgTM3EJnjPI35I9LfVtLXPYHHI3Jboy3MQAOYNjF1WCxBACK6LMtTLRPyoTeS1ZskAFz4JfKEbN-1mtV9hFgaZ37pLo2SEP4UsWr4KqQlaD8-YUs-kZcC2zK4YIJ_Jmvtr2X4AmCptV-7k_IHv3QNNg
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZQeygXKM-G8nClckKp1nacxMcoolpgd1WVrdRb5KcqdckWkr3w6zuTZLdQqLRHOxMrtseZb-SZbwg5zo1PVBpsrHzgcWKcjrXXIc65sFKbMNIaE4Wns3R8kXy9lJdDsjrmwsBHNDBS013i37ELIE0QdHIL3gOm6-0CDuGo0EX5_S4NkudsjXazPBVDnPv9t9EO2eZvO_QPuPyvHepszulTMtt8bRdqcn2yas2J_X2PyHHr6eyTJwP6pEWvLs_II18_J3vluujbC_KzWFxrRJ707GrZ3FzpFqxcXPbx7AtMs6K6dvTcOzrpKEgK29VHg_b5rKDTpcPQo263aTHQlVPAxfQMWTQaT-erH9DCWqJ9AG79klycfp6X43ioyhBrAF9tbAJXLFfOieCClEI6CS6fVMJlQid-5KwBTKdCmmeJM5kMLg_ZKEjLMsY9Z-IV2amXtT8gVCP88pkaAYZMUgvelLDG4bkFyyqFicgRLFM1nKqm6i7MOTgs2DssXkQ-rfexsgOtOVbXWDwg_XEjfdPTeTwgd7RWiQp2AC9RdO2XKxAA_y5Ns0SJiLzudWUzkgC4Cz9IFpHjP5Vn8xwBl8IKYKq7VIkI20asHGaFJAXtmy2W5APZG8-nk2ryZfbtkDzmmLDBeMzZW7LT_lr5dwCjWvO-Ozy3XwQVlw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqIgEX3pTwdKVyQqnWdpzExyiwKtCuVksr9Rb5qUpdsgvJXvj1zOSxQKFSOSaZWLE9znyjmfmGkIPc-ESlwcbKBx4nxulYex3inAsrtQkTrbFQ-GSWHp0ln87l-Q5hYy0MfEQDIzVdEB9P9dqFgWEAqYLgAbfgQWDJ3i2M2KFSF-WXX6WQPGcj4s3yVAy57lffRltkmz9t0V8A85-2qLM70_tksf3iLt3k8nDTmkP74wqZ439N6QG5N6BQWvRq85Ds-PoRuVOOzd8ek2_F8lIjAqXzi1WzvtAtWLu47PPal1huRXXt6MI7etxRkRS265MG14tZQU9WDlOQul2nxUBbTgEf0zmyaTSenm6-whX2FO0Tcesn5Gz64bQ8iofuDLEGENbGJnDFcuWcCC5IKaST4PpJJVwmdOInzhrAdiqkeZY4k8ng8pBNgrQsY9xzJp6S3XpV-2eEaoRhPlMTwJJJasGrEtY4PL9gYaUwEdmHZaqG09VUXeCcg-OCd4fFi8i7cS8rO9CbY5eN5TXSb7fS657W4xq5_VEtKtgBDKbo2q82IAB-XppmiRIR2ev1ZTuSANgLP0oWkYPfFWj7HIGXwk5gqguuRITdRKwcZoVkBe3zGyzJG3J7_n5aHX-cfX5B7nKs22A85uwl2W2_b_wrQFOted2dn59qihga
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alkaline+Phosphatase-Controllable+and+Red+Light-Activated+RNA+Modification+Approach+for+Precise+Tumor+Suppression&rft.jtitle=Journal+of+the+American+Chemical+Society&rft.au=Fang%2C+Jing&rft.au=Feng%2C+Yali&rft.au=Zhang%2C+Yuqi&rft.au=Wang%2C+Anna&rft.date=2022-12-21&rft.pub=American+Chemical+Society&rft.issn=0002-7863&rft.eissn=1520-5126&rft.volume=144&rft.issue=50&rft.spage=23061&rft.epage=23072&rft_id=info:doi/10.1021%2Fjacs.2c10409&rft.externalDocID=a364479660
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-7863&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-7863&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-7863&client=summon